YK-11 (5mg/capsule), 60 Capsules

Description

YK-11 (5 mg/capsule) – 60 Capsules

YK-11 is an experimental steroidal compound that has attracted scientific interest because of its interaction with androgen receptor signaling and its observed activity in laboratory cell models. This PurePeptideEU listing contains YK-11 at a stated concentration of 5 mg per capsule, with 60 capsules supplied per container.

The product should be regarded exclusively as a research material. YK-11 is not an approved medicine, dietary supplement, bodybuilding supplement, or therapeutic product and should not be represented as one.

What Is YK-11?

YK-11 is commonly discussed within the selective androgen receptor modulator research field. Published laboratory research has characterized YK-11 as a partial agonist of the androgen receptor. Early in-vitro research investigated how the compound affects androgen-receptor signaling and gene expression.

A subsequent laboratory study using C2C12 mouse myoblast cells investigated YK-11 in relation to myogenic differentiation and follistatin expression. These experiments are an important part of the scientific literature surrounding YK-11, but laboratory findings should not be interpreted as evidence of safety or effectiveness in humans.

Human clinical evidence for YK-11 remains extremely limited. Consequently, claims about established therapeutic benefits, recommended human dosages, treatment schedules or predictable duration of effects would not be scientifically justified.

Composition

Each capsule in this product is specified to contain 5 mg of YK-11. With 60 capsules per container, the package represents 300 mg of nominal YK-11 content in total.

YK-11 has the molecular formula C25H34O6 and is also identified by CAS number 1370003-76-1. Its scientific chemical identity is considerably longer and is generally abbreviated to YK-11 in research literature.

Any capsule excipients, carrier ingredients, purity percentage, batch number and analytical verification should be taken directly from the manufacturer’s current product specification and batch-specific Certificate of Analysis rather than assumed from the product name.

Research Applications

YK-11 has primarily been investigated in preclinical laboratory settings. Published research has examined areas including androgen receptor activation, receptor-mediated gene expression, myogenic differentiation and follistatin-associated cellular mechanisms.

Researchers reviewing YK-11 should distinguish clearly between observations made in cultured cells and demonstrated effects in humans. Preclinical observations do not establish clinical effectiveness, safety, appropriate dosage or therapeutic value.

For professional research environments, appropriate documentation is particularly important. Product identity, batch information, analytical testing methodology, purity data and storage requirements should be verified using the documentation accompanying the specific batch.

Safety and Regulatory Information

YK-11 has not been approved by the U.S. Food and Drug Administration for human therapeutic use. FDA has warned that products marketed as SARMs are unapproved drugs and has identified potentially serious health concerns associated with this category.

Accordingly, this product should not be marketed or interpreted as a medicine, dietary supplement, performance-enhancement product or substitute for an approved treatment.

No human administration instructions, cycle recommendations or dosage protocols are provided because an established safe human-use protocol for YK-11 has not been demonstrated.

Research-First Product Information

PurePeptideEU should provide researchers with accurate, batch-specific information rather than unsupported efficacy or safety claims. Where available, researchers should consult the corresponding Certificate of Analysis for analytical results, product identity and relevant batch information before conducting laboratory work.